News

According to the American Academy of Dermatology, moisturizing and cleansing are crucial to treating atopic dermatitis, yet 23% of adults with eczema do not use a moisturizer to

According to the company, preclinical research into this combination offers compelling evidence for entering clinical trials, largely because IL-21 (Interleukin 21) appears to enhance a principal mechanism by

The company is attempting to gain approval for satraplatin in combination with prednisone as a second-line chemotherapy treatment for patients with hormone-refractory prostate cancer (HRPC). Satraplatin for this

As a result, Teva Neuroscience, Teva’s US marketing subsidiary, will have sole responsibility for the marketing of Azilect in the US and Teva will no longer share profits

The phase I trial of CB7630, an orally active inhibitor of the steroidal enzyme 17alpha-hydroxylase/C17,20 lyase, will be conducted at the University of California San Francisco Comprehensive Cancer

In 2005, Xoma entered into a $15 million contract with the National Institute of Allergy and Infectious Diseases (NIAID) to develop cell lines, optimize production processes and manufacture

“Earlier this year HHS joined the nation’s governors for a series of state pandemic influenza summits,” said HHS Secretary Michael Leavitt. “These funds will build on the work

An infusion form of the drug is currently undergoing advanced clinical testing with the FDA. The drug is used to treat congenital emphysema, caused by an in-born deficiency

The fusion protein consists of Alfacell’s investigational anticancer drug Onconase (ranpirnase) and a humanized anti-CD22 monoclonal antibody. “This fusion protein and other new molecular forms of Onconase will